It is the contention of FSG that modern biotechnology is a potent and novel technology that presents unique risks. This means that whatever the perceived benefits seen in advances in biotechnology, they must be developed and used with adequate safety measures for the environment and human health. This is why international conventions such as the Cartagena Protocol on Biosafety (CPB), and the Convention on Biological Diversity (CBD) regulating its safe use need to be respected, hence our application for the injunction.